Androgen Secretion in Ectopic ACTH Syndrome and in Cushing’s Disease: Modifications Before and After Surgery

The role of ACTH in the control of adrenal androgen secretion is known, although the possible existence of other regulatory factors has been also suggested. While some data concerning Cushing’s disease have been reported, only few studies concerned androgen levels in ectopic ACTH secretion. The aim of this study was to evaluate serum DHEA-S, androstenedione (A) and testosterone (T) levels in 36 women with ACTH-dependent Cushing’s syndrome (30 with Cushing’s disease and 6 with ectopic ACTH secretion) before and after surgery. Two men with ectopic ACTH production were also studied. In 30 women with Cushing’s disease serum DHEA-S (9.6 ± 0.9 µmol/l), A (15.2 ± 1.2 nmol/l) and T (4.1 ± 0.5 nmol/l) were higher than in controls (p < 0.01): elevated DHEA-S, A and T values were found in 8, 18 and 17 cases, respectively. After adenomectomy in 15 apparently cured patients DHEA-S, A and T levels were low at 1 - 3 months and at 6 - 12 months after surgery. At 18 - 24 months, DHEA-S remained low in spite of cortisol normalisation. In ectopic Cushing’s syndrome, A levels were significantly higher (23.1 ± 4.9 nmol/l) than in Cushing’s disease (p < 0.05), while no differences were found in DHEA-S and T levels. Two patients had elevated DHEA-S values, 3 women had high T levels and 7 of the 8 patients had very high A concentration that was lowered in 3 operated cases. In conclusion, the pattern of adrenal androgen secretion is rather different in patients with pituitary or with ectopic Cushing’s syndrome. While the frequency of DHEA-S and T alterations is similar, androstenedione secretion is greatly increased in the latter condition. It is suggested that in ACTH-secreting non-pituitary tumours, the production of a POMC-derived peptide, although unidentified, may lead to preferentially stimulated androstenedione secretion, without affecting other enzymatic pathways.

Key words:

Hypercortisolism - Androgens - Corticotropin - Androstenedione - Hypothalamic-Pituitary-Adrenal Axis - Cortisol

References

• 1 De Peretti E, Forest M. Unconjugated dehydroepiandrosterone plasma levels in normal subjects from birth to adolescence in humans: the use of a sensitive radioimmunoassay.  J Clin Endocrinol Metab. 1976;  43 982-991
• 2 Parker L N. Control of adrenal androgen secretion.  Endocrinol Metab Clin North Am. 1991;  20 401-421
• 3 Fujieda K, Faiman C, Feydes F, Winter J. The control of steroidogenesis by human fetal adrenal cells in tissue culture: the effects of exposure to placental steroids.  J Clin Endocrinol Metab. 1982;  54 89-94
• 4 Parker L N, Eugene J, Farber D, Lifrak E T, Lai M, Juler G. Dissociation of adrenal androgen and cortisol levels in acute stress.  Horm Metab Res. 1985;  17 209-212
• 5 Parker L N, Levin E R, Lifrak E T. Evidence for adrenocortical adaptation to severe illness.  J Clin Endocrinol Metab. 1985;  60 947-952
• 6 Osran H, Reist C, Chen C C, Lifrak E T, Chicz-DeMet A, Parker L N. Adrenal androgens and cortisol in major depression.  Am J Psych. 1993;  150 806-809
• 7 Zumoff B, Walsh B, Katz J, Rosenfeld R, Kream J, Weiner H. Subnormal plasma dehydroepiandrosterone to cortisol ratio in anorexia nervosa: a second hormone parameter of ontogenic regression.  J Clin Endocrinol Metab. 1983;  56 668-672
• 8 Rittmaster R S, Loriaux D L, Cutler G B. Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women.  J Clin Endocrinol Metab. 1985;  61 462-466
• 9 Cutler GB J r, Davis S E, Johnsonbaugh R E, Loriaux D L. Dissociation of cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency.  J Clin Endocrinol Metab. 1979;  49 604-609
• 10 Yamaji T, Ishibashi M, Takaku F, ItabashiA, Katayama S, Ishii J. Serum dehydroepiandrosterone sulfate concentrations in secondary adrenal insufficiency.  J Clin Endocrinol Metab. 1987;  65 448-451
• 11 Ambrosi B, Bochicchio D, Peverelli S, Ferrario R, Faglia G. Value of serum dehydroepiandrosterone sulfate assay in the evaluation of pituitary-adrenal insufficiency after pituitary adenomectomy.  J Endocrinol Invest. 1992;  15 827-835
• 12 Hauffa B P, Kaplan S L, Grumbach M M. Dissociation between plasma adrenal androgens and cortisol in Cushing’s disease and ectopic ACTH-producing tumour: relation to adrenarche.  Lancet. 1984;  23 1373-1376
• 13 Yamaji T, Ishibashi M, Sekihara H, Itabashi A, Yanaihara T. Serum dehydroepiandrosterone sulfate in Cushing’s syndrome.  J Clin Endocrinol Metab. 1984;  59 1164-1168
• 14 Kleiber H, Rey F, Temler E, Gomez F. Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing’s syndrome.  J Endocrinol Invest. 1991;  14 489-492
• 15 Cunningham S K, McKenna T J. Dissociation of adrenal androgen and cortisol secretion in Cushing’s syndrome.  Clin Endocrinol. 1994;  41 795-800
• 16 Fearon U, Clarke D, McKenna T J, Cunningham S K. Intra-adrenal factors are not involved in the differential control of cortisol and adrenal androgens in human adrenals.  Eur J Endocrinol. 1988;  138 567-573
• 17 Wajchenberg B L, Mendoça B, Liberman B, Albergaria Pereira M A, Campos Carneiro P, Wakamatsu A, Kirschner M A. Ectopic adrenocorticotropic hormone syndrome.  Endocr Rev. 1994;  15 752-787
• 18 Ferriman D, Gallwey J D. Clinical assessment of body hair growth in women.  J Clin Endocrinol Metab. 1961;  21 1440-1447
• 19 Lado-Abeal J, Rodriguez-Arnao J, Newell-Price J DC, Perry L A, Grossman A B, Besser G M, Trainer P J. Menstrual abnormalities in women with Cushing’s disease are correlated with hypercortisolemia rather than raised circulating androgen levels.  J Clin Endocrinol Metab. 1998;  83 3083-3088
• 20 Halpin D MG, Burrin J M, Joplin G F. Serum testosterone levels in women with Cushing’s disease.  Acta Endocrinol (Copenh). 1990;  1 71-75
• 21 Vierhapper H, Nowotny P, Waldhausl W. Production rates of testosterone in patients with Cushing’s syndrome.  Metabolism. 2000;  49 229-231
• 22 Yen S SC. The polycystic ovary syndrome.  Clin Endocrinol. 1980;  12 177-208
• 23 Weber M M, Luppa P, Engelhardt D. Inhibition of human adrenal androgen secretion by ketoconazole.  Klin Wochenschr. 1989;  67 707-712
• 24 Parker L N, Lifrak E, Gelfand R, Shively J, Lee T, Kaplan B, Walker P, Calaycay J, Florsheim W, Mason I, Soon-Shiong P. Isolation, purification, synthesis and binding of human adrenal gland cortical androgen stimulating hormone.  Endocr J. 1993;  1 441-445
• 25 Mellon S H, Shively J E, Miller W L. Human pro-opiomelanocortin-(79 - 96), a proposed androgen stimulatory hormone, does not affect steroidogenesis in cultured human fetal adrenal cells.  J Clin Endocrinol Metab. 1991;  72 19-22
• 26 Penhoat A, Sanchez P, Jaillard C, Langlois D, Begeot M, Saez J M. Human pro-opiomelanocortin-(79-96), a proposed androgen-stimulating hormone, does not affect steroidogenesis in cultured human adult adrenal cells.  J Clin Endocrinol Metab. 1991;  72 23-26
• 27 Brubaker P L, Baird A, Bennet H, Browne C, Solomon S. Corticotropic peptides in the human fetal pituitary.  Endocrinology. 1982;  111 1150-1155
• 28 Parker L N, Lifrak E T, Odell W D. A 60 000 molecular weight human pituitary glycoprotein stimulates adrenal androgen secretion.  Endocrinology. 1983;  113 2092-2096
• 29 Clarke D, Fearon U, Cunningham S K, McKenna T J. The steroidogenic effects of β-endorphin and joining peptide: a potential role in the modulation of adrenal androgen production.  J Endocrinol. 1996;  151 301-307
• 30 Ibanez L, Potau N, Marcos M V, de Zegher F. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche.  J Clin Endocrinol Metab. 1999;  84 4602-4606
• 31 Ibanez L, Potau N, Marcos M V, de Zegher F. Corticotropin-releasing hormone as adrenal androgen secretagogue.  Pediatr Res. 1999;  46 351-353